Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,712,301
+$2,381,681 QoQ
Shares Held
632,238
+607.5% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Man Group plc holds $1,080,100,046 across 125 Biotechnology names. NUVB ranks #42 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
315,212 | $243,545,399 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
236,798 | $105,739,778 | |
| 3 | INCY |
Incyte Corp
|
930,171 | $87,547,693 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
232,369 | $76,883,931 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
241,922 | $71,843,576 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
915,689 | $36,838,167 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
275,270 | $26,770,006 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
135,212 | $25,561,828 |
All Filings in NUVB
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,712,301 | 632,238 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $330,620 | 89,357 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $75,295 | 38,613 | Shares | Defined | 2025-08-14 | |
| 2024-06-30 | $323,027 | 110,626 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $947,415 | 260,279 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $359,878 | 238,330 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $123,424 | 55,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $174,636 | 53,900 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $76,270 | 14,500 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||